Former pharmaceutical company executive Richard Domann has joined Kerr Drug’s Kerr Health subsidiary.


Richard Domann, Kerr Drug, Kerr Health, drug industry, pharmaceutical, Anthony Civello, McNeil, GlaxoSmithKline










































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Inside This Issue - News

Kerr appoints Domann as VP

August 16th, 2010

RALEIGH, N.C. – Former pharmaceutical company executive Richard Domann has joined Kerr Drug’s Kerr Health subsidiary.

Domann, who has more than three decades of experience in the drug industry, is the company’s vice president of sales and business development.

“Dick’s immense pharmaceutical background makes him a wonderful addition to our team,” Kerr chief executive officer Anthony Civello remarks. “He is highly regarded both in the industry and in the community,” Civello says. “He is truly a first-class addition to the Kerr family. We are excited for the opportunities that will come from his many relationships and his industry expertise.”

Domann began his career in 1980 with McNeil Pharmaceuticals and joined Glaxo Pharmaceuticals three years later.

As the company evolved into GlaxoSmithKline, he held a variety of positions, including territory sales representative, district sales manager, director of government development, director of strategic trade operations, managed markets chief of staff and segment vice president of channel sales.

Since moving to North Carolina in 1987, Domann has served on several charitable foundation boards and has been actively involved in North Carolina politics.

He has also had his first novel, The Ghost on Number 2, published and is currently working on a second book.

Advertisement